FDA has approved Abrysvo for active immunization for the prevention of lower respiratory tract disease caused by RSV.

Nursing home residents with respiratory syncytial virus (RSV) have high risk for illness, frequent hospitalization, and high mortality.

Identifying IFN transcription pathways both during health and acute respiratory infection will help us understand whether what is described as “impaired IFN expression” is a result of physiological ...

Additionally, S100A4, JAML, TRAF3IP3, MIAT, IL7R, and KLRB1 were found to be significantly expressed in the immune pathway associated with allograft rejection. Within the metabolic pathway, an ...

RSV is a highly contagious virus affecting the respiratory system, especially dangerous for infants, young children, and pregnant women. It leads to symptoms ranging from mild colds to severe ...

Respiratory virus data included in the interactive data application is up-to-date as of October 12, 2024. Among its new features, the dashboard now includes RSV Severe Outcomes data.

which are given in the fall when respiratory diseases circulate. Moderna and CSL both said they were not manufacturing vaccines at that plant during either FDA visit. Thermo Fisher's Greenville ...

So she was delighted when, last year, health authorities in the US and Europe approved the first vaccines for respiratory syncytial virus. RSV vaccines hold the potential to reduce the thousands ...

HOUSTON, Texas (KTRK) -- Respiratory syncytial virus, or RSV, is the leading cause of hospitalizations for infants. It's a major risk for older children, too, and can be dangerous, even life ...

The infectious virus, similar to Ebola, was first traced to patients in health facilities. Officials confirmed 36 cases this week. [Illustration: smartboy10/DigitalVision/Getty Images] BY Tracy ...